MedTrace Logo

Program Evaluation of Telehomecare: TeLeCare Study

NCT02311114 · Status: UNKNOWN · Type: OBSERVATIONAL

Last updated 2018-03-22

No results posted yet for this study

Summary

This study will evaluate the Telehomecare (THC) Program offered to patients with heart failure or chronic obstructive pulmonary disease across the Central West, Toronto Central and North East Local Health Integration Networks in Ontario. It will explore the opinions and experiences of patients, providers, technicians and administrators involved with THC Program in order to provide stakeholders with information about the processes and organizational factors impacting the program's adoption, the experiences of its participants, impact on patient outcomes, costs to the health-care system and who is benefiting the most from participating. These factors will be determined using semi-structured interviews, surveys, and observation of practices of everyone involved with THC. The study will also evaluate patient data to determine changes in patients' utilization of healthcare services.

Conditions

Interventions

OTHER

In Depth interview

In Depth interview will be conducted for 30-60 min using semi-structured questionnaire to assess participants experience with telehomecare program.

OTHER

Observational fieldwork

Observational fieldwork will conducted to observe everyday routine activities related to telehomecare. May last up to 1h per observation.

OTHER

Survey

Surveys with participants will be conducted using validated survey tools.

Sponsors & Collaborators

  • Ontario Ministry of Health and Long Term Care

    collaborator OTHER_GOV

  • University of Toronto

    lead OTHER

Principal Investigators

  • Murray Krahn, MD,MSc · THETA Collaborative

  • Valeria Rac, MD, PhD · THETA Collaborative

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2014-12-31
Completion
2018-09-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02311114 on ClinicalTrials.gov